| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |